Product Code: ETC12875119 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Itraconazole Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Itraconazole Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Itraconazole Market - Industry Life Cycle |
3.4 Israel Itraconazole Market - Porter's Five Forces |
3.5 Israel Itraconazole Market Revenues & Volume Share, By Formulation, 2021 & 2031F |
3.6 Israel Itraconazole Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Itraconazole Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Itraconazole Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of fungal infections in Israel |
4.2.2 Growing awareness about the benefits of itraconazole in treating fungal infections |
4.2.3 Rising demand for antifungal medications in the healthcare sector |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Israel |
4.3.2 Competition from alternative antifungal medications |
4.3.3 High cost associated with itraconazole treatment |
5 Israel Itraconazole Market Trends |
6 Israel Itraconazole Market, By Types |
6.1 Israel Itraconazole Market, By Formulation |
6.1.1 Overview and Analysis |
6.1.2 Israel Itraconazole Market Revenues & Volume, By Formulation, 2021 - 2031F |
6.1.3 Israel Itraconazole Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.1.4 Israel Itraconazole Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.5 Israel Itraconazole Market Revenues & Volume, By Oral Solution, 2021 - 2031F |
6.1.6 Israel Itraconazole Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.2 Israel Itraconazole Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Itraconazole Market Revenues & Volume, By Systemic Fungal Infections, 2021 - 2031F |
6.2.3 Israel Itraconazole Market Revenues & Volume, By Dermatophytosis, 2021 - 2031F |
6.2.4 Israel Itraconazole Market Revenues & Volume, By Aspergillosis, 2021 - 2031F |
6.3 Israel Itraconazole Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Israel Itraconazole Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Israel Itraconazole Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.3.4 Israel Itraconazole Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 Israel Itraconazole Market Import-Export Trade Statistics |
7.1 Israel Itraconazole Market Export to Major Countries |
7.2 Israel Itraconazole Market Imports from Major Countries |
8 Israel Itraconazole Market Key Performance Indicators |
8.1 Number of prescriptions for itraconazole |
8.2 Patient adherence rate to itraconazole treatment |
8.3 Rate of new product development in the antifungal medication market |
9 Israel Itraconazole Market - Opportunity Assessment |
9.1 Israel Itraconazole Market Opportunity Assessment, By Formulation, 2021 & 2031F |
9.2 Israel Itraconazole Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Itraconazole Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Itraconazole Market - Competitive Landscape |
10.1 Israel Itraconazole Market Revenue Share, By Companies, 2024 |
10.2 Israel Itraconazole Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |